Stay updated with breaking news from Equillium Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the...
Equillium, Inc. (NASDAQ:EQ – Free Report) – Investment analysts at HC Wainwright boosted their Q3 2024 earnings per share estimates for shares of Equillium in a report released on Friday, May 17th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings per share of $0.89 for the quarter, up from their […]
Equillium (NASDAQ:EQ – Free Report) had its target price lifted by HC Wainwright from $4.00 to $5.00 in a research note published on Tuesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Equillium’s Q2 2024 earnings at ($0.06) EPS, Q3 2024 earnings at $0.88 […]
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
$40.9 million cash balance at the end of 2023 expected to provide cash runway into 2H 2025 Completed enrollment of Phase 2 clinical study of EQ101 in alopecia areata: topline data expected in Q2...